Pepdox
Studies
Peptides
Calculator
Newer classes of antidiabetes drugs: ophthalmological considerations for GLP-1R agonists, DPP-4 inhibitors, and SGLT-2 inhibitors. | Pepdox
Home
/
Search
/
PMID 29074013
Newer classes of antidiabetes drugs: ophthalmological considerations for GLP-1R agonists, DPP-4 inhibitors, and SGLT-2 inhibitors.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2017
PMID: 29074013
View on PubMed
DOI: 10.1016/j.jcjo.2017.07.028
Semaglutide
Authors
McReelis, Kylen D; Lovshin, Julie A